内皮功能障碍:川崎病的分子机制和治疗策略
Lucia Paolini1, Fiorentina Guida2, Antonino Calvaruso1
1Specialty School of Paediatrics, Alma Mater Studiorum, University of Bologna, 40139 Bologna, Italy.
International journal of molecular sciences
|January 8, 2025
概括
川崎病 (KD) 涉及内皮功能障碍 (ED),影响儿童的心脏健康. 在KD中研究ED提供治疗目标,以减少心血管并发症并改善长期结果.
科学领域:
- 血管生物学 血管生物学
- 儿科风湿病学 儿科风湿病学
- 心脏病学 心脏病学
背景情况:
- 内皮功能障碍 (ED) 与血管炎有关,这是一组血管炎症状况.
- 川崎病 (KD) 是一种主要的儿童血管炎,由于冠状动脉损伤导致获得的心脏病.
- 勃起障碍与KD的发病有关,导致显著的心血管发病率和死亡率.
研究的目的:
- 审查关于川崎病发病因中的内皮功能障碍的当前知识.
- 探索ED在KD对治疗策略的实际影响.
- 确定缓解KD患者心血管并发症的潜在目标.
主要方法:
- 文献综述专注于川崎病中的内皮功能障碍.
- 分析关于ED与KD心血管结果之间联系的现有研究.
- 综合当前的理解和识别研究差距.
主要成果:
- 内皮功能障碍是川崎病中心血管并发症发展的关键因素.
- 了解KD中ED机制可以指导针对性治疗的开发.
- 目前的治疗策略旨在控制炎症并预防冠状动脉动脉瘤.
结论:
- 解决内皮功能障碍对于改善川崎病的心血管结果至关重要.
- 需要进一步的研究来将动物模型的发现转化为KD心血管病变的临床应用.
- 针对ED提供了一个有希望的途径,以限制KD幸存者的长期心血管疾病.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
133
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
133
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381


